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Introduction
HEV is an RNA virus that was first recognised in 1983 
as an etiological agent of hepatits E, an acute disease 
that is often icteric but which does not tend to become 
chronic. It is generally self-limiting, with an incubation 
period ranging from 15 to 60 days. The main character-
istic of this infection is the high frequency of fulminant 
clinical forms (1-12%) which takes a particularly severe 
course in pregnant women, especially in the third trimes-
ter, with mortality rates reaching as high as 40% [1-16].
Although the epidemiology of HEV is still not fully 
understood, it is certain that the mode of transmission 
is fecal-oral, in particular via water contaminated with 
sewage and this therefore constitutes a useful investiga-
tory tool for epidemiological studies [2].
The spread of this disease is greater in geographical 
areas with inadequate standards of health and hygiene 
where both sporadic cases and epidemics may appear. 
Epidemics have recently been recorded in India, Burma, 
Iran, Bangladesh, Ethiopia, Nepal, Algeria, Libya, So-
malia, Indonesia, Mexico, China, Pakistan, in former 
Soviet Central Asian Republics [3-6]. In countries with 
high standards of health and hygiene, the majority of 
cases are people returning from travels to countries at 
risk (imported cases) while to a lesser extent they are 
due to autoctonic strains of HEV [1]. 
In Italy, a study by Zanetti and Dawson showed 10% 
of hepatitis cases (not A-C) to be caused by HEV, often 
found in persons of other nationalities. Moreover, the 
same research isolated for the first time a strain of HEV 
in a patient who had neither travelled nor been in contact 
with anyone returning from endemic areas thus demon-
strating the existence of actoctonic HEV strains [7-9].
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Aim
To contribute to the definition of the epidemiological 
framework of hepatitis E by means of a study of HEV 
in sewage taken from two wastewater treatment plants 
in the city of Messina: one municipal plant and the other 
of the University hospital (AOU).
In particular, the analysis of the wastewater from the lat-
ter plant focuses the field of research on a specific sector 
of the population.
Materials and methods
In this study we studied samples of sewage entering 
and exiting the activated sludge sewage treatment plant, 
serving the municipality of Messina, located in Mili in 
the area of Barone, and the treatment plant for Messina 
University hospital situated onsite. The samples, 22 for 
the council plant and 24 for the hospital plant, were col-
lected monthly over nearly a year from 14 April 2006 to 
31 March 2007. 
The samples of untreated and treated sewage (2 litre) 
were stored at -80°C until they were tested, after being 
defrosted and left to settle for two hours.
Samples were concentrated by tangential-flow ultrafil-
tration.
Tangential-flow ultrafiltration
This method uses a peristaltic pump fitted with a cellu-
lose membrane with a mesh size of 10000 Dalton Milli-
pore. The membrane was pretreated (in order to saturate 
the sites present on it) by allowing a 0.3% meat extract 
solution at pH 7 to circulate in the column. After ultra-
filtration, the samples underwent filtration using 40ml 
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of a 3% meat extract solution concentration at pH 9, the 
solution was left to act for 10 minutes to enable any viral 
particles stuck to the membrane to be recovered. 
This treatment yielded 15-20 ml of concentrated sample, 
which was then used to detect HEV using the molecular 
biological technique Reverse transcription polymerase 
chain reaction (RT-PCR) method (“HEV RNA pres-
ence” kit, Symbiosis, Asti, Italy). In brief, this method 
consists of three fundamental phases: extraction of the 
RNA, reverse transcriptation and amplification with 
specific primers, and colorimetric detection of the am-
plified products on plates.
RNA extraction
The RNA of HEV was extracted from each sample us-
ing the “Qiagen” method (Qiagen, Milan, Italy) starting 
with aliquots of 140 μL of concentrated sample. After 
various rinse phases lo eliminate the aspecific impurities 
bound to the silica gel, the RNA was collected by elut-
ing it from the fixing solution using a specific buffer.
Reverse transcriptation and amplification
The reverse transcriptase-PCR “RT- PCR “technique re-
alised in two step: in the first “reverse transciption”10µl 
of RNA extracted from each sample was added up to 
the final volume of 30µl, with 1.5µl “antisense”primer 
(5’-CCTCGAAGCAGTAAGTGCGGTC-3’), at the 
temperature of 37°C for 30 minutes and at 95°C for 5 
minutes, in the second step “amplification phase”, 20µl 
of the reverse transcribed samples product of the first 
step was added up to a final volume of 50 µl, with 1 ul of 
“sense” primer (5’-GGCTCCTGGCATCACTACTG-
3’), 0.3 ul of Taq, it was then placed in a thermal cycler 
1 cycle at 95°C for 5 minutes and 5 times at a cycle of 
95°C for 50 seconds, at 57°C for 30 seconds and at 72°C 
for 1 minutes, and 35 times at a cycle of 95°C for 30 
seconds, at 57°C for 30 seconds; at 72°C for 45seconds; 
lastly to 1 cycle of 10 minutes at 72°C. 
Colorimetric detection 
Five µl of the amplification products and of the controls 
are first hybridised in microtubes with 120 µl of a spe-
cific probe at the temperature of 95°C for 5 minutes, 
and at 37°C for 10 minutes. The hybridisation process 
consists in annealing a molecule of fluorescein to the 
biotin-labelled 5’ end of the amplified DNA, 45 µl of the 
hybridised product was placed in the wells of a micro-
plate and incubated for 1 hour at 37°C to allow it to fix 
to the walls of the wells. After rinsing to eliminate the 
unfixed hybridised product in excess, 100 µl of conju-
gated-HRP solution (antibody anti-fluorescein horserad-
ish peroxidase), was added to each well. The microplate 
was then placed on an agitator at room temperature for 
30 minutes. After further rinsing for the elimination of 
the conjugated product in excess, 100µl of chromogenic 
substrate (orthophenylenediamine -OPD) were added to 
each well and the microplate incubated at room temper-
ature for 30 minutes. If the antigen-conjugated complex 
was present, colour developed on the plate. Its intensity 
was proportional to the concentration of the fixed com-
plex. After 30 minutes, the reaction was blocked with 
a solution of hydrochloric acid, and the microplate was 
transferred to a spectrophotometer for densitometry at 
450 nm and 630 nm. The cut-off value beyond which 
the sample was considered positive for the presence of 
HEV-RNA, was given by doubling the average of the 
optical density values of the negative controls.
Results
Three of the 46 sewage samples examined (15.33%) 
tested positive for HEV by RT-PCR. Two of these three 
samples came from the untreated sewage entering the 
University hospital treatment plant and one was raw 
sewage entering the municipal plant at Mili. No trace 
of HEV was found in any of the samples taken of the 
treated wastewater exiting the two plants. The presence 
of the virus in the sewage sample taken from the hos-
pital plant (8.33%) was found in samples collected dur-
ing spring months, in May and June, while the sample 
containing the virus (4.5%) in the municipal plant was 
collected in September.
Discussion and conclusions
The results obtained confirm the presence of the hepa-
titis E virus in the city of Messina, as previously found 
in a seroprevalance study conducted by Squeri et. al. in 
1996 in which the rate was 3.93% [10]. Other studies 
carried out in Italy have reported a seroprevalance rate 
of 2.9% in the total population of the city of Lecce, 
4.3% in hemodialysis patients and in 15.3% of immi-
grants [11]. The seroprevalence found for the general 
population of Italy has been reported in the range of 1% 
and 5%, a fairly high percentage considering that reports 
of the disease are quite rare with a higher rate of anti-
HEV antibodies (1%-6%) being found in hemodialysis 
patients, drug addicts and subjects found positive for 
markers of post-transfusion viral hepatitis [7, 8, 12]. 
Several seroepidemiological studies have also shown 
high rates of anti-HEV antibodies in a significant pro-
portion of healthy individuals (5-20%) in industrialised 
countries, including regular blood donors. This sug-
gests that the disease is present, albeit at a subclinical 
level [13]. 
The risk of contracting the infection is greater in Sic-
ily which is located at the centre of the Mediterranean 
where HEV is present in numerous countries and which 
has a significant number of non European residents, a 
higher incidence of pathologies transmitted by fecal-
oral means and a tradition of eating raw shellfish. 
The higher presence of the virus found in the sewage 
entering the hospital plant may be attributed to hospital 
patients who are receiving dialysis, drug addicts and non 
Europeans [14, 15].
In conclusion, the results confirm the HEV virus to be 
in circulation in Messina, although to a modest extent. It 
may be favoured by the presence of numerous non Eu-
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ropeans coming from countries in which the disease is 
endemic or where there are poor standards of health and 
hygiene, or by people returning from visits to countries 
at risk [14]. 
Our study also showed the two treatment plants tested 
to be working effectively, insofar as HEV was identified 
solely in samples entering the plants.
Our study underlines the need for greater epidemiologi-
cal surveillance regarding this disease since prevention 
of HEV, in the current absence of a vaccine, depends 
on general measures to control enterically transmit-
ted infections, this means improving not only health 
and hygiene conditions but also tightening controls on 
water. 
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